Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 274 No 7350 p602
21 May 2005

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Health responsibilities reconfigured as new minister given pharmacy

Jane Kennedy

Jane Kennedy takes over from Rosie Winterton

Jane Kennedy, the newly appointed Minister of State for quality and patient safety has been given the pharmacy portfolio previously assigned to Rosie Winterton.

Ms Kennedy’s other responsibilities include standards, inspection and performance, patient safety including the National Patient Safety Agency, clinical governance and quality issues, clinical negligence, methicillin-resistant Staphylococcus aureus, reducing bureaucracy, the National Institute for Health and Clinical Excellence, genetics, the Medicines and Healthcare products Regulatory Agency and medicines, the pharmaceutical industry, research and development, counter fraud and departmental management.

Although Ms Kennedy is responsible for pharmacy, other ministers’ responsibilities will overlap to some extent. For example, Ms Winterton’s new portfolio as Minister of State for health services includes prison health care, which has become an NHS function in which primary care trusts have a role. Her other responsibilities are for international and EU business, emergency preparedness, cancer services, cardiac services, diabetes services, mental health, dentistry, patient and public involvement, renal services and equality and diversity issues.

The Royal Pharmaceutical Society’s President has written to the Secretary of State and to the new pharmacy minister to introduce the Society and to outline the profession’s key concerns for the immediate future.

Director of public affairs and communications Beverley Parkin said: “The Society established an excellent working relationship with its ministers in the last Government. We shall be working hard to ensure that the profession continues to have the ear of the new Government as we go forward.”

Sue Sharpe, Pharmaceutical Services Negotiating Committee chief executive, commented: “We had an immensely good relationship with Rosie Winterton. She really did see the potential of community pharmacy and worked with us and she was a tremendous supporter of community pharmacy. At the moment we don’t know Jane Kennedy. We’ve written to her to welcome her to her new post and we’ll seek an early meeting with her.”

Back to Top


©The Pharmaceutical Journal